SNTI
SNTI
NASDAQ · Biotechnology

Senti Biosciences Inc

$1.10
-0.01 (-0.90%)
As of Jun 30, 10:47 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +194.5% upside
Low Target $1.82
Average Target $3.24
High Target $4.40
Current Price $1.10
Current
$1.10
Target
$3.24
$1.82 $3.24 avg $4.40
Scenario Analysis
Bear Case
$1.82
65.5%
Low target
Base Case
$3.24
+194.5%
Avg target
Bull Case
$4.40
+300.0%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$2.88
-61.8% from high
52-Week Low
$0.77
+42.8% from low
Target vs 52W High
$3.24
+12.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%